1 00:00:02,040 --> 00:00:12,060 From the plague of Athens to the Spanish flu and from the Black Death to the Ebola outbreak, we've taken a journey through a litany of human misery. 2 00:00:12,060 --> 00:00:23,820 And as you listen now, we're experiencing another devastating pandemic, Kovik, 19, caused by the source code to virus, but could be worse yet to come. 3 00:00:23,820 --> 00:00:25,260 In 2015, 4 00:00:25,260 --> 00:00:34,560 the World Health Organisation asked a group of global experts to draught a shortlist of serious emerging infectious diseases around the world. 5 00:00:34,560 --> 00:00:43,020 The idea was to focus research and development on them to try to stop future outbreaks from turning into a public health emergency. 6 00:00:43,020 --> 00:00:54,270 The list contained some diseases. We discussed Ebola and songs and many we happened, including Zika, Lassa fever and Marburg virus in 2018. 7 00:00:54,270 --> 00:01:01,380 After meeting in Geneva, the team added one more name to the list Disease X, 8 00:01:01,380 --> 00:01:09,960 a place holder for an unknown hypothetical pathogen that might pose a future epidemic. 9 00:01:09,960 --> 00:01:18,000 Welcome back to the present day and welldone the making it through all of the diseases, not history of pandemics. 10 00:01:18,000 --> 00:01:26,690 In today's bonus episode, I interview the Oxford scientists working at the forefront of research into Disease X 11 00:01:26,690 --> 00:01:33,810 and discuss what we may or may not have learnt from experience of Koven along the way. 12 00:01:33,810 --> 00:01:38,400 I'll include a few discussions which couldn't quite get into the main series, 13 00:01:38,400 --> 00:01:44,130 including a conversation I had about whether a focus on pandemic masks the real problem. 14 00:01:44,130 --> 00:01:48,790 Humanity faces ongoing endemic diseases on the way. 15 00:01:48,790 --> 00:01:56,950 I'm Professor Sarah Gilbert, now world famous for her work on Oxford's Coronado's and Professor Peter 4B, 16 00:01:56,950 --> 00:02:03,300 co chief investigator of the trial, discovered that dexamethasone could be a lifesaving drug. 17 00:02:03,300 --> 00:02:09,150 First up, though, it's a John Bell Regis professor of medicine at Oxford. 18 00:02:09,150 --> 00:02:14,310 I began by asking John where he was when he first heard about Kovik. 19 00:02:14,310 --> 00:02:20,900 I was going about my daily routine in that principle, first over and then over Christmas. 20 00:02:20,900 --> 00:02:31,230 Twenty nineteen. I had a communication from Jeremy Ferrer, who is director of the Wellcome Trust and who is pretty in tune with emerging infections. 21 00:02:31,230 --> 00:02:36,360 Of course, he ran our unit in Vietnam at the time of the H5N1 avian flu epidemic. 22 00:02:36,360 --> 00:02:42,960 So he's pretty much linked in to all the epidemiologists and clinical scientists who do this in Asia. 23 00:02:42,960 --> 00:02:46,940 And the message I got from him is there's trouble brewing in central China. 24 00:02:46,940 --> 00:02:52,380 And it looks like there's quite a serious epidemic brewing there. 25 00:02:52,380 --> 00:02:55,710 Lots of sick people not care of the data. We're on it. 26 00:02:55,710 --> 00:03:01,710 Be careful because this may find its way into a pandemic. So that was pretty interesting. 27 00:03:01,710 --> 00:03:11,580 And George goWe, who worked in my lab for many years and went back and is assigned to the director of the CDC in China, was also in touch. 28 00:03:11,580 --> 00:03:19,230 And that was clear that they were really under pressure in China because they learnt rather too late about the epidemic. 29 00:03:19,230 --> 00:03:24,870 So they moved in to try and work out how to contain it. But it was clearly very, very serious. 30 00:03:24,870 --> 00:03:33,120 And it was really about that time that things started to leak into the press about there being a serious problem in central China. 31 00:03:33,120 --> 00:03:39,890 And then that sort of blew up in early January. The sequence was published the end of the first week of January, and then it all went from there. 32 00:03:39,890 --> 00:03:44,850 But it happened pretty quickly, you know, really literally over a three or four week period. 33 00:03:44,850 --> 00:03:51,090 It was pretty clear to me from they were almost from the initial descriptions that this was going to be bad. 34 00:03:51,090 --> 00:03:59,520 And I'm not a doomsayer, but I had been watching out for pandemic threats for a number of years. 35 00:03:59,520 --> 00:04:04,620 And the H5 N1 epidemic was pretty worrying. 36 00:04:04,620 --> 00:04:08,850 And we were really only saved by the fact the pathogen didn't transmit from human to human. 37 00:04:08,850 --> 00:04:13,560 It was only from birds to humans, but it carried a really high mortality. 38 00:04:13,560 --> 00:04:20,040 I think the numbers were between 30 and 50 percent. Scar's one adult, 35 percent mortality. 39 00:04:20,040 --> 00:04:25,080 And since the year 2000, we've had eight of those close calls. 40 00:04:25,080 --> 00:04:28,590 We've had two Saar's outbreaks, each self-contained. 41 00:04:28,590 --> 00:04:37,410 The murres outbreak, self contained, avian flu constrained by its inability to transmit between humans. 42 00:04:37,410 --> 00:04:43,050 Another avian flu in China since then, which again has been limited. 43 00:04:43,050 --> 00:04:49,740 And then, of course, the 2014 flu epidemic, which actually is global but wasn't as severe as we expected. 44 00:04:49,740 --> 00:04:59,670 And then we had Ebola and then we had Zika. So, you know, look, there's a whole set of these pathogens that are coming in to the world and appearing. 45 00:04:59,670 --> 00:05:03,680 And we've just been. Really lucky that none of them had blown up. 46 00:05:03,680 --> 00:05:10,280 So when I heard about this, I thought, you know, this may be the big one and it may become pandemic pretty quickly. 47 00:05:10,280 --> 00:05:15,850 And to be clear, at that stage, we knew nothing about the pathogen. We didn't know how many people were symptomatic. 48 00:05:15,850 --> 00:05:19,550 Coming to give or asymptomatic. We didn't know how it was spread. 49 00:05:19,550 --> 00:05:23,570 We didn't know what the case fatality rate was likely to be. 50 00:05:23,570 --> 00:05:29,810 We didn't know anything. And so it didn't need to be a quite a lot of work to work out what was going on. 51 00:05:29,810 --> 00:05:36,770 So I thought of this as being a problem. Very early by the end of December, I am pretty sure this is going to be a massive issue. 52 00:05:36,770 --> 00:05:44,300 And it was also pretty clear to me from the end of December that Oxford probably had quite a lot to contribute to this because first of all, 53 00:05:44,300 --> 00:05:49,340 our units globally will be in a good position to provide surveillance data. 54 00:05:49,340 --> 00:06:01,400 We had terrific contacts in China. We had terrific contacts elsewhere in Asia and of course, elsewhere in the global health space. 55 00:06:01,400 --> 00:06:13,010 And we had very, very powerful capabilities in vaccines, but also in testing and also in drug trials in all the areas which Oxford came to dominate. 56 00:06:13,010 --> 00:06:20,390 It was clear to me that we could actually make a big play. And now, nearly a year into tackling this disease. 57 00:06:20,390 --> 00:06:26,270 I wondered what lessons John thought we've already learnt. You could write a book on the lessons learnt. 58 00:06:26,270 --> 00:06:32,960 The real risk is that people will forget the lessons learnt and we'll go back to business as usual from next year. 59 00:06:32,960 --> 00:06:39,080 But the first big lesson is don't be complacent about the threat of a pandemic. 60 00:06:39,080 --> 00:06:48,260 The speed at which it can occur and the need to have real preparedness in place and to move quickly when you start to see it coming. 61 00:06:48,260 --> 00:06:52,160 You can't afford to say, oh, it'll burn itself out. It'll all be fine. 62 00:06:52,160 --> 00:06:58,400 Don't need to worry. And worst of all, the NHS is prepared because none of those things are true. 63 00:06:58,400 --> 00:07:04,970 And I think the failure in this country not to move quicker is a deep national embarrassment. 64 00:07:04,970 --> 00:07:09,440 Frankly, wasn't as if we didn't know about these things. And it wasn't as if people weren't told. 65 00:07:09,440 --> 00:07:15,830 They just chose not to do anything. I'll tell you, our problem, though, is we only know what we know. 66 00:07:15,830 --> 00:07:20,630 And of course, we know what we know from history. And you guys just bit over the history. 67 00:07:20,630 --> 00:07:26,960 The scary thing is what we don't know, and that may prove to be very tricky. 68 00:07:26,960 --> 00:07:31,910 And I mean, it's fair to say we knew a bit about this, but we didn't know much about this when it arrived. 69 00:07:31,910 --> 00:07:42,560 I think that's one of the big challenges. But I also have to say that the incredible efforts of the science community to interrogate this pathogen, 70 00:07:42,560 --> 00:07:44,780 understand how it worked, what it looked like, 71 00:07:44,780 --> 00:07:54,380 every bit of its genome and all its aspects of pathogenicity and and its infectiousness has been done in an unbelievably short period of time. 72 00:07:54,380 --> 00:08:01,400 And now we're sitting here with three good vaccines, the best of which is undoubtedly the Oxford vaccine. 73 00:08:01,400 --> 00:08:05,720 And we're ready to go and fight back in a pretty serious way. 74 00:08:05,720 --> 00:08:14,550 So, you know, the fight back has begun. But in that story, there's dexamethasone which came from the recovery trial. 75 00:08:14,550 --> 00:08:20,270 There's the mass testing programme with lots of flow tests, which has been led by Derek Warkentin Pito. 76 00:08:20,270 --> 00:08:28,200 There are any number of great stories that are hugely led by Oxford scientists. 77 00:08:28,200 --> 00:08:33,120 Moving on to future risks. Our main focus in today's episode. 78 00:08:33,120 --> 00:08:39,480 I was interested to ask John whether there are notan diseases we should be wary of or whether 79 00:08:39,480 --> 00:08:45,960 the pathogens that lead to major outbreaks are often entirely unknown until they strike. 80 00:08:45,960 --> 00:08:54,300 In reality, we do occasionally get a new outbreak of a pathogen that we haven't previously identified and characterise. 81 00:08:54,300 --> 00:09:03,090 So a good example of that is Lyme disease, which is spread by ticks in the east coast of the U.S. Legionnaires disease, 82 00:09:03,090 --> 00:09:09,540 which is an aerosol spread, pneumonia, which we didn't know and understand. 83 00:09:09,540 --> 00:09:16,350 There haven't been big outbreaks. They can start small. We tend to understand them better, and then we get a read on the pathogens. 84 00:09:16,350 --> 00:09:25,410 So we're in better position to know what's going on. So most of the things that blow up on a global scale we've seen before now quite a 85 00:09:25,410 --> 00:09:30,870 bit of documentation about the list of respiratory viral pathogens in particular, 86 00:09:30,870 --> 00:09:36,660 which I think are probably the biggest single risk that might potentially cause trouble. 87 00:09:36,660 --> 00:09:43,740 So, for example, when Ebola blew up in West Africa, we knew about it had been discovered ten, fifteen years before Nipah virus. 88 00:09:43,740 --> 00:09:53,790 There's been a few small outbreaks of Nipah. We know about that. Saar's Kobe one appeared in Hong Kong and then was transported to Canada. 89 00:09:53,790 --> 00:09:58,630 That was a class virus that we didn't know very much about. But we now know quite a lot about that class. 90 00:09:58,630 --> 00:10:03,960 And there's a whole family of Sabor virus. It's obviously better corona that potentially cause trouble. 91 00:10:03,960 --> 00:10:07,590 So there's steady progress and knowing what's out there. 92 00:10:07,590 --> 00:10:15,870 Now, each of the individual pathogens that cause disease will probably be different than the previous one. 93 00:10:15,870 --> 00:10:22,260 But we know a lot about the family, as it were. So we didn't go into this epidemic with no knowledge of Saar's. 94 00:10:22,260 --> 00:10:28,320 We just didn't have specific insights into Saras be to which we now do. 95 00:10:28,320 --> 00:10:31,560 So, yeah, so it's not as if we don't know what to prepare for. 96 00:10:31,560 --> 00:10:40,110 We do know what to prepare for and we know how to get the various assets in place to deal with an epidemic more efficiently than this one. 97 00:10:40,110 --> 00:10:43,770 I think the two or three big ones are still flu. 98 00:10:43,770 --> 00:10:51,990 Flu is still the biggest single threat in my view. It varies pretty substantially from year to year. 99 00:10:51,990 --> 00:10:59,130 There is a lot of avian disease out there that could, with a few mutations, become spread from humans and humans. 100 00:10:59,130 --> 00:11:07,830 At its worst, it carries a really high mortality. And of course, the great flu epidemic of 1917 1918 carried away, you know, 101 00:11:07,830 --> 00:11:12,180 somewhere between 50 and under a million people, depending on how you're counting it up. 102 00:11:12,180 --> 00:11:14,700 I think, in my view, that's still top of the list, 103 00:11:14,700 --> 00:11:20,830 that Corona viruses were probably always second on my list partment because the Saras and the murres outbreaks, 104 00:11:20,830 --> 00:11:27,910 there was always question about what it would take to produce one that actually had real pandemic capabilities. 105 00:11:27,910 --> 00:11:33,090 But we now know that that can happen. So I think that's the second big class. 106 00:11:33,090 --> 00:11:38,520 And then class of viruses that sit around Ebola are probably also still a risk. 107 00:11:38,520 --> 00:11:44,880 They're spread very, very effectively. They're infectivity is very high from human to human. 108 00:11:44,880 --> 00:11:49,530 That is another family of viruses I would worry about a lot. 109 00:11:49,530 --> 00:11:55,520 But there are only three of a long list. So we do need to be thinking about what that list looks like. 110 00:11:55,520 --> 00:12:03,720 John's list didn't include anti-microbial resistance, which came up during a number of my discussions with guests for the series. 111 00:12:03,720 --> 00:12:12,360 So I asked him why he left it out. Thing is, there is a little bit of antimicrobial resistance, but it's very little. 112 00:12:12,360 --> 00:12:17,850 Some pathogens, TB, it's a serious problem in TB and gram negative organisms. 113 00:12:17,850 --> 00:12:19,320 You're seeing more of it. 114 00:12:19,320 --> 00:12:24,540 But, you know, it hasn't swept the world and you don't have thousands of people dying and they will get their total hips down. 115 00:12:24,540 --> 00:12:28,280 Do you I mean, it's just basically isn't there. And to be clear. 116 00:12:28,280 --> 00:12:36,330 We've been talking about it for 10 years. So I think there is a bit of a problem about hyping these things up too early. 117 00:12:36,330 --> 00:12:43,530 I would say that's probably an example of one. And it also doesn't help to beat up the pharmaceutical industry because, 118 00:12:43,530 --> 00:12:48,090 you know, there's been lots of bleeding to say that pharma industry is at fault. 119 00:12:48,090 --> 00:12:57,600 The truth is, it's a massive example of market failure, because if you make an antibiotic to gram negative pathogens, 120 00:12:57,600 --> 00:13:02,070 you are resistant to the usual antibiotics that you use it. 121 00:13:02,070 --> 00:13:07,380 For those infections, you could easily spend a billion dollars making the product. 122 00:13:07,380 --> 00:13:11,760 And what are you going to do, sell it to 400 people a year? How is that going to work? 123 00:13:11,760 --> 00:13:14,940 So, you know, government really wanted to have this happen. 124 00:13:14,940 --> 00:13:22,770 They would have put pre-orders in for these things so that a company knew if they made one, they could get a return on investment. 125 00:13:22,770 --> 00:13:27,650 But nobody has done that. So I think it's not. 126 00:13:27,650 --> 00:13:35,000 I wouldn't put antimicrobial resistance in my top list of things I wake up at night worrying about. 127 00:13:35,000 --> 00:13:42,440 I mean, I had some experience on this because I have been on the board of Roesch for many years and the course had Tamiflu and is now gone. 128 00:13:42,440 --> 00:13:50,860 So she's had since got the only two really good anti flu medicines and they spent a lot of money developing Tamiflu and then they couldn't sell it. 129 00:13:50,860 --> 00:13:53,930 I mean, really, literally, they could not sell any. 130 00:13:53,930 --> 00:14:02,510 And it was a real problem until avian flu came along and everyone went, oh, anybody got an anti flu drug? 131 00:14:02,510 --> 00:14:06,920 And then suddenly they sold two billion dollars worth in a year. 132 00:14:06,920 --> 00:14:12,060 Right. And then the following year, everybody said, well, there's no flu epidemic this year. 133 00:14:12,060 --> 00:14:16,730 We're going to stop buying it. So it went from two billion in sales back down to nothing again. 134 00:14:16,730 --> 00:14:22,220 So, you know, if you're running a company that's not very out there, it creates its own problems. 135 00:14:22,220 --> 00:14:27,450 These infected medicines, it's a it's a real issue. 136 00:14:27,450 --> 00:14:35,550 With all of these potential threats in mind, I was really keen to hear John's view on how we should prepare for future pandemics. 137 00:14:35,550 --> 00:14:42,120 This is a really interesting story, and I've been a bit involved in the national planning for pandemic preparedness, 138 00:14:42,120 --> 00:14:47,600 which is largely being led out of number 10, but also the Cabinet Office, as you know. 139 00:14:47,600 --> 00:14:56,850 Boris Johnson gave a speech, a U.N. speech about this a month or six weeks ago and indeed cited those eight examples of close calls that have occurred 140 00:14:56,850 --> 00:15:05,010 since the year 2000 as a warning harbinger that there's likely to be more trouble in the not too distant future. 141 00:15:05,010 --> 00:15:14,880 So the way I think about this is there's several boxes of activity that we probably need to establish is ongoing, 142 00:15:14,880 --> 00:15:20,040 sustainable functions of the global community to deal with pandemics. 143 00:15:20,040 --> 00:15:27,600 And the first one really relates to the ability to have better surveillance and a better heads up as to what's happening. 144 00:15:27,600 --> 00:15:38,220 Quick pathogen identification, global surveillance for outbreaks of severe disease have put people in intensive care units around the world, 145 00:15:38,220 --> 00:15:43,710 rapid identification, probably by genomic sequencing, which is the quickest way to do that. 146 00:15:43,710 --> 00:15:49,200 And we need a network of centres that do that so we can see what's coming and what isn't coming. 147 00:15:49,200 --> 00:15:54,510 So that's probably the first and most important initial capability. 148 00:15:54,510 --> 00:16:02,550 It's probably also worth thinking about whether we have a sort of nine one one team that can drop into these sites, 149 00:16:02,550 --> 00:16:12,070 which is a sort of rapid response group. I mean, Peter Harvey does some of this and of course, a huge advocate of quick response to pandemics. 150 00:16:12,070 --> 00:16:17,580 And he's probably as experienced as anybody in dealing with these emerging infections. 151 00:16:17,580 --> 00:16:22,360 So I think you use our words very serious consideration. 152 00:16:22,360 --> 00:16:27,210 So that surveillance piece is a crucial piece. We need good data. 153 00:16:27,210 --> 00:16:37,080 Global data, whether we see through lots of ZEW, not organisms, organisms that are found in the animal species, I think is a debateable issue. 154 00:16:37,080 --> 00:16:43,770 I mean, some people have argued, well, why don't we have a massive programme on animal pathogens that might pass from animals to humans? 155 00:16:43,770 --> 00:16:48,540 I mean, it's a great thing. It's great. That's a great soundbite. But, boy, is that a hard job. 156 00:16:48,540 --> 00:16:54,900 Because there are there are literally millions of those potential pathogens out there. 157 00:16:54,900 --> 00:16:58,800 I mean, just take bats alone. They're full of all kinds of pathogens. 158 00:16:58,800 --> 00:17:02,310 And if you go across multiple animal species, you can find lots and lots. 159 00:17:02,310 --> 00:17:06,720 And I'm not entirely sure what you do with that information because you'll end up with a great long list. 160 00:17:06,720 --> 00:17:13,110 But how you pick potential threats from ones that are not is quite challenging. 161 00:17:13,110 --> 00:17:17,760 So that's the surveillance box that the second box is. 162 00:17:17,760 --> 00:17:26,040 What do you do about having their reagents available to respond to a new epidemic with, 163 00:17:26,040 --> 00:17:32,550 for example, a new virus, a new member of a viral family, a new flu, new corona virus, whatever? 164 00:17:32,550 --> 00:17:37,680 And the answer is that there's quite a lot you can do now to get yourself ready for that. 165 00:17:37,680 --> 00:17:40,950 And these were all areas where we were clearly failing, 166 00:17:40,950 --> 00:17:49,260 at least in the UK and actually globally in terms of being prepared for this event, for example, with vaccines. 167 00:17:49,260 --> 00:17:58,170 There are now at least two vaccine platforms, RNA and adenovirus, both of which have shown that they can produce vaccines pretty quickly. 168 00:17:58,170 --> 00:18:09,570 And so there is an interesting question about can you pre-empt some of that activity that needs to be done early by creating model vaccines, 169 00:18:09,570 --> 00:18:15,720 checking their immunogenicity and normal people, making sure they generate strong neutralising immune responses, 170 00:18:15,720 --> 00:18:19,690 all that kind of stuff, even if you don't know the precise pathogen. 171 00:18:19,690 --> 00:18:24,810 You know, as Sara Gilbert's great success was migrating quickly from a Meurs programme, 172 00:18:24,810 --> 00:18:32,310 which she'd run very successfully into a Saras Kobe to programme, and being on the front foot for this is really important. 173 00:18:32,310 --> 00:18:38,300 And when you look at the Jenner portfolio, they're working on twelve emerging pathogens. 174 00:18:38,300 --> 00:18:46,380 So there are sort of already all over this. It would be good also to have an RNA programme that could be pretty interesting as a potential play. 175 00:18:46,380 --> 00:18:51,060 You can imagine getting range of vaccine platforms ready to go. 176 00:18:51,060 --> 00:18:56,580 That could move quickly in the face of a new family member that perhaps didn't have 177 00:18:56,580 --> 00:19:03,120 crossed reacting immunogenicity with previous infections as it was for COGAT 19. 178 00:19:03,120 --> 00:19:08,400 The second one is drugs. So it's an interesting question whether we could do a better job with drugs. 179 00:19:08,400 --> 00:19:13,920 This is not commercially very viable because you can make an antiviral against a Saras pathogen. 180 00:19:13,920 --> 00:19:17,610 You're not going to sell it to anybody. So it's got to be subsidised by government. 181 00:19:17,610 --> 00:19:27,110 But would it have been better if we'd had more model drugs targeted at, for example, the RNA dependent RNA polymerase, which is. 182 00:19:27,110 --> 00:19:35,160 Sweet spot in these Corona viruses or to the protease, which, again, is a potential sweet spot for this. 183 00:19:35,160 --> 00:19:44,670 And could we have a set of small molecule libraries that have been tuned and honed to target those particular targets across a range of emerging 184 00:19:44,670 --> 00:19:49,560 pathogens so that we had a better chance of moving quickly to find a molecule 185 00:19:49,560 --> 00:19:54,600 that you could use in patients now that when you look back at the epidemic, 186 00:19:54,600 --> 00:20:01,140 that's quite a hard sell. And the reason is, let's say in January, you said, let's get the library out. 187 00:20:01,140 --> 00:20:04,670 We know what this pathogen looks like. We've got the crystal structure, the protease. 188 00:20:04,670 --> 00:20:10,890 Let's make a protease inhibitor. Well, you could have got to a protease inhibitor probably pretty quickly by the summer. 189 00:20:10,890 --> 00:20:15,460 I would've thought. But then you got it in safe to study and you got to do trials. 190 00:20:15,460 --> 00:20:21,720 You got to do all that. So, I mean, Pfizer's going to protease inhibitor, as you know, to cope with 19. 191 00:20:21,720 --> 00:20:25,440 They're probably going to get licence just about the time the pandemic goes away. 192 00:20:25,440 --> 00:20:31,560 So you'd have to be pretty clever to get those things in place in a timely way. 193 00:20:31,560 --> 00:20:36,270 I think a better option, of course, is repurposing drugs in their recovery. 194 00:20:36,270 --> 00:20:43,680 You spoke to Peter Hornby. It's a good example of how repurposing has very substantial benefits in this setting. 195 00:20:43,680 --> 00:20:47,630 But then the other big play is antibody therapies. 196 00:20:47,630 --> 00:20:52,530 So monoclonal antibodies for this disease are going to prove to be very important role. 197 00:20:52,530 --> 00:20:56,400 I think they're very potent than virals. And again, 198 00:20:56,400 --> 00:21:00,670 we only started making those antibodies when the first convalesced serum started coming in 199 00:21:00,670 --> 00:21:05,790 and we started to clone the B cells that produce the antibodies and then characterise them. 200 00:21:05,790 --> 00:21:12,180 And of course, as soon as you've got a lot of sick people, it's quite easy to make a lot of monoclonal antibodies to these diseases. 201 00:21:12,180 --> 00:21:16,020 And I think we need to be prepared to do that and think about how we would set that up. 202 00:21:16,020 --> 00:21:23,040 But a final bit of that story is I become very intrigued by broadly neutralising 203 00:21:23,040 --> 00:21:29,400 antibodies so that basically antibodies that react to Saras Kohji to that they are 204 00:21:29,400 --> 00:21:33,870 equally effective against Saras coli one and they're equally effective against all 205 00:21:33,870 --> 00:21:38,400 the members of that family because they've designed a protein epitopes in Spike, 206 00:21:38,400 --> 00:21:47,250 which are shared between all those viruses and people been working on broadly energising antibodies for HIV for a long time. 207 00:21:47,250 --> 00:21:52,410 And there's been some beautiful work done, but in respiratory viruses, nobody's really focussed on that. 208 00:21:52,410 --> 00:22:02,190 And I think that's possibly the idea. So I've seen three broadly neutralising antibodies that seem to neutralise all the members of that Saras family. 209 00:22:02,190 --> 00:22:04,950 And there's about 10 members that we know about now. 210 00:22:04,950 --> 00:22:12,960 And so you think to yourself, well, Hammet, if you actually had those antibodies, those antibodies that would neutralise anything in the family, 211 00:22:12,960 --> 00:22:17,460 then I think you could make a very good argument of growing those up, lie off, slicing them, 212 00:22:17,460 --> 00:22:23,400 sticking them on the shelves, literally sticking a billion in them on the shelves so that you've got a buffer, 213 00:22:23,400 --> 00:22:31,380 because if they've been appropriately modified by modifying the F.C. receptor, they last, you know, four to six months after an infusion. 214 00:22:31,380 --> 00:22:39,930 So you could give yourself a buffer against just another Sari's virus infection by simply having a massive supply of those things. 215 00:22:39,930 --> 00:22:45,900 So, you know, that's another bit of a therapeutic vaccine piece that we need to develop. 216 00:22:45,900 --> 00:22:51,240 And then, of course, there's diagnostics. So we've had a huge amount of diagnostics, innovation in this epidemic. 217 00:22:51,240 --> 00:22:54,600 And I think we've got to continue to do that because it turns out that knowing who's 218 00:22:54,600 --> 00:22:59,550 got the disease is the first and most fundamental piece of knowing what's going on. 219 00:22:59,550 --> 00:23:07,920 Mostly, this has been PCR driven in most countries in the West, but there probably are better ways to do these diagnostics. 220 00:23:07,920 --> 00:23:13,050 And I think we do need a bit of innovation in this space to get better diagnostics, 221 00:23:13,050 --> 00:23:17,370 which you would probably have to conceive of in the early weeks of the epidemic. 222 00:23:17,370 --> 00:23:21,410 But you could probably move down the road very quickly. So that's the second. 223 00:23:21,410 --> 00:23:26,850 Boxton third box is really about data and clinical trials. 224 00:23:26,850 --> 00:23:35,790 We need an international standard for data. We've got to have groups that are ready to go to launch clinical trials as an international consortium. 225 00:23:35,790 --> 00:23:44,010 Almost immediately. You've got to have data sharing agreements that allows you to put data from the trials into a cloud that everybody can access. 226 00:23:44,010 --> 00:23:48,750 And you've got to have standards of data that allows different countries to know that 227 00:23:48,750 --> 00:23:53,700 their data is basically on the same standards as the French data and the German data, 228 00:23:53,700 --> 00:23:59,610 American data and the Australian data, because it did at the moment in this pandemic, all the data's everywhere. 229 00:23:59,610 --> 00:24:03,900 So you'd have no idea what he's doing, what to whom, which is a real problem. 230 00:24:03,900 --> 00:24:10,710 So that's a box of clinical trials. And data is another very important piece of the puzzle. 231 00:24:10,710 --> 00:24:15,840 And then there is a piece around manufacturing, which I think is also crucial. 232 00:24:15,840 --> 00:24:23,410 And that is we got caught without any substantial manufacturing capabilities in the UK, least none that we knew about. 233 00:24:23,410 --> 00:24:30,500 And V-neck Centre, which had been funded through the life sciences industrial strategy three years ago, three and a half years ago. 234 00:24:30,500 --> 00:24:37,110 They're having cleared a bit of ground it was supposed to sit on. So they were able to hasten the speed of that. 235 00:24:37,110 --> 00:24:43,740 But it's still not going to be ready till after the pandemic. So we need vaccine manufacturing capability. 236 00:24:43,740 --> 00:24:50,130 We need antibody manufacturing capability, and we need diagnostics, manufacturing capability. 237 00:24:50,130 --> 00:24:55,440 That's the other big box. And then the final big box is regulation. 238 00:24:55,440 --> 00:25:04,980 One of those things slow this down in this endemic is that we use the usual routes to approve or not approve individual medicines, 239 00:25:04,980 --> 00:25:12,120 diagnostics, antibody, selex. And I think there's an argument in the presence of a pandemic to change those 240 00:25:12,120 --> 00:25:17,970 rules so that you don't get tied down by the constraints of the regulatory system, 241 00:25:17,970 --> 00:25:25,990 which basically means you can't move fast enough. Now, I say that incomplete knowledge at the MHRA has been terrific in this pandemic. 242 00:25:25,990 --> 00:25:32,310 But they too have been caught by the rules where they have to do certain things, which I think if they had thought about it, 243 00:25:32,310 --> 00:25:41,640 they would have preferred not to ask for those kind of those kind of results or derogations because just should have been waved through. 244 00:25:41,640 --> 00:25:50,130 So I'm pretty sure that that will be a crucial bit of the puzzle is to try and get the regulatory right and the communications thing right. 245 00:25:50,130 --> 00:25:55,230 So that's another box. But those are the five or six things that I think are crucial. 246 00:25:55,230 --> 00:26:01,740 Next is Peter Hopea, professor of Emerging Infectious Diseases and global health at Oxford. 247 00:26:01,740 --> 00:26:11,760 As with John, I began by asking Peter where he was when he first heard about convened by the executive director of an organisation called a Sorich, 248 00:26:11,760 --> 00:26:18,600 which is the International Severe Acute Respiratory and Emerging Infections Consortium, which has got partners all over the world. 249 00:26:18,600 --> 00:26:23,880 And so I have very strong links, longstanding collaborations with colleagues in China. 250 00:26:23,880 --> 00:26:26,490 So I knew immediately that we would be involved somehow. 251 00:26:26,490 --> 00:26:33,270 And actually, the first contact with colleagues in China was on the 2nd of January, just a few days after the outbreak was announced. 252 00:26:33,270 --> 00:26:38,070 And it turns out that one of our close collaborators was nominated by the Beijing government 253 00:26:38,070 --> 00:26:44,400 to be the lead on clinical research for this new virus and was sent to him to investigate. 254 00:26:44,400 --> 00:26:48,660 And he rang up and we had on 2nd of January, it was serious. 255 00:26:48,660 --> 00:26:53,820 I've seen no outbreaks of soslan and bird flu in the past year. 256 00:26:53,820 --> 00:26:58,680 I'm from the clinical descriptions and from my conversations with my colleague in China, 257 00:26:58,680 --> 00:27:02,820 which we were having every night at about midnight and 2nd of January, 258 00:27:02,820 --> 00:27:08,280 it became clear that it was a serious illness, that it was transmissible from person to person. 259 00:27:08,280 --> 00:27:13,670 So it was clear pretty early that this was a serious virus and a serious outbreak. 260 00:27:13,670 --> 00:27:19,530 I don't think it became clear that it would be a pandemic, as in that it would spread around the world until quite a bit later. 261 00:27:19,530 --> 00:27:25,880 Initially, we saw some cases outside of China, but it didn't really seem to cause much onward transmission. 262 00:27:25,880 --> 00:27:32,160 They were taking control. So early spikes in Thailand and elsewhere. 263 00:27:32,160 --> 00:27:41,220 But I think what we then saw was continued spread outside of China and then it became pretty apparent some sort of sometime in February. 264 00:27:41,220 --> 00:27:50,040 This could be very difficult to contain. Peter and his colleagues immediately went about organising a new clinical trial to test the 265 00:27:50,040 --> 00:27:55,630 effects of numerous already known treatments on patients admitted to hospital with Kobe, 266 00:27:55,630 --> 00:28:00,660 19. This was called the randomised evaluation of Kuvin 19. 267 00:28:00,660 --> 00:28:06,940 Therapy, trial or recovery for short. They knew they'd have to act quickly. 268 00:28:06,940 --> 00:28:12,580 What we've learnt in the past is that business as usual doesn't work for epidemics or pandemics. 269 00:28:12,580 --> 00:28:16,410 They're very challenging for lots of reasons. They're very quick. 270 00:28:16,410 --> 00:28:22,690 They're hard to predict where they're going to occur. The health care system and individuals are under great pressure, 271 00:28:22,690 --> 00:28:28,360 both in terms of running the day to day jobs skills and in terms of political and other pressures. 272 00:28:28,360 --> 00:28:30,960 So you really have to have a different mindset. 273 00:28:30,960 --> 00:28:36,900 And what we've seen in the past is the usual sort of clinical research or other types of research that are done, 274 00:28:36,900 --> 00:28:40,270 just not done at the pace and the way they need to be done in epidemics. 275 00:28:40,270 --> 00:28:48,010 As an example, clinical trials testing new drugs in patients often take 18 months to set up. 276 00:28:48,010 --> 00:28:56,950 News don't have that time. You don't have eight months. In fact, many epidemic waves are about six weeks so that the pandemic may last a long time. 277 00:28:56,950 --> 00:29:00,880 And then any one individual area, you get a wave. So you need to be ready for that. 278 00:29:00,880 --> 00:29:11,820 So what we we learnt with our experiences with songs, the bird flu and the 2009 influenza pandemic is you must have a great sense of urgency. 279 00:29:11,820 --> 00:29:14,770 You have to move very, very quickly. And that's what we did. 280 00:29:14,770 --> 00:29:19,340 And it was the right thing to do because it meant that we could capture the patients in the first wave of 281 00:29:19,340 --> 00:29:24,820 the illness and really make some progress in understanding this disease and finding new treatments for it. 282 00:29:24,820 --> 00:29:33,180 One of the key issues is that we need to have pretty big Charles detective, modest aflex of drugs and most benefits. 283 00:29:33,180 --> 00:29:37,150 The drugs are fairly modest and so we need to have thousands of patients now. 284 00:29:37,150 --> 00:29:41,660 Enrolling thousands of patients during an epidemic is challenging because you only have limited time, 285 00:29:41,660 --> 00:29:45,910 but also the health care staff are under a great deal of stress and pressure. 286 00:29:45,910 --> 00:29:47,560 So the first thing is it needs to be very simple. 287 00:29:47,560 --> 00:29:56,440 So we designed it to be a very, very simple trial that could be used at the front line by doctors and nurses under pressure during the epidemic. 288 00:29:56,440 --> 00:29:59,770 And because of that simplicity, we were able to roll it out very quickly. 289 00:29:59,770 --> 00:30:09,250 So I think we broke some records, retime from when we had the first draught of the protocol to the first patient enrolled was just nine days, 290 00:30:09,250 --> 00:30:12,250 which I think that's a record that will never be beaten. 291 00:30:12,250 --> 00:30:17,780 And then within two weeks, we enrolled nearly a thousand patients and within eight weeks, ten thousand patients. 292 00:30:17,780 --> 00:30:21,740 So it was really highly successful and we built it so it could be adaptable. 293 00:30:21,740 --> 00:30:26,860 So we built it so that we could and can move drugs and no evidence became available. 294 00:30:26,860 --> 00:30:32,500 And that's what's happened today. At the time that we're recording this, we called the result on three drugs, 295 00:30:32,500 --> 00:30:36,350 one of which takes measures that were successful, two of which were not successful. 296 00:30:36,350 --> 00:30:41,170 And we've still got five drugs in the trial and we keep updating them. 297 00:30:41,170 --> 00:30:44,050 So we've recently added an example. 298 00:30:44,050 --> 00:30:50,590 I want to call an antibody and then we know that, again, aspirin, and then we will be introducing more drugs as time goes on. 299 00:30:50,590 --> 00:30:58,180 So as we learn more about this virus in which drugs might be effective, we can slot them into the platform trying to recover. 300 00:30:58,180 --> 00:31:05,080 The speed of the recovery investigation, as well as what it's already achieved, was hugely impressive. 301 00:31:05,080 --> 00:31:10,710 And I asked Peter for his reflections on that. I reflect on it almost daily. 302 00:31:10,710 --> 00:31:13,190 It's it's an incredible achievement, I think. 303 00:31:13,190 --> 00:31:21,380 And I'm not saying to bolster my own, the achievement is really a fabulous clinical trials team that have been setting this up. 304 00:31:21,380 --> 00:31:29,640 And also the huge support we've had some chest than the national health mostue research infrastructure and support from government, 305 00:31:29,640 --> 00:31:33,470 from the chief medical officer and the doctor, chief medical officer has made this possible. 306 00:31:33,470 --> 00:31:39,410 And I think about this. I think, you know, this is the best thing that I've been involved in in my career. 307 00:31:39,410 --> 00:31:41,300 And this really made a difference. 308 00:31:41,300 --> 00:31:47,660 And it's something we can all be very, very proud of as a country and which we need to make sure we replicate in the future, 309 00:31:47,660 --> 00:31:52,250 not just in the UK, but elsewhere, because it really has been very effective. 310 00:31:52,250 --> 00:31:58,130 And we need to make this asset available globally in the light of this experience. 311 00:31:58,130 --> 00:32:03,710 I asked Peter what key lessons can be learnt about preparing for future pandemics. 312 00:32:03,710 --> 00:32:08,000 There are many things we need, but the top three probably are the will to do it. 313 00:32:08,000 --> 00:32:16,190 That's political will and will from universities, research, sexual research, condos, et cetera, to really make this happen. 314 00:32:16,190 --> 00:32:23,750 It's very hard to make an argument that will second it comes the investment because you do need resources to make this work. 315 00:32:23,750 --> 00:32:28,430 And what you need is resources that are there in peacetime as well as in times of crisis, 316 00:32:28,430 --> 00:32:33,090 because you can't suddenly create that infrastructure when there's a crisis, you need to have it in place. 317 00:32:33,090 --> 00:32:40,070 And that was one of the successes of options. We had a lot of the work done, a lot of the experience in the bank, and we had the technology is there. 318 00:32:40,070 --> 00:32:45,740 So you need that investment during peacetime. So it's your insurance policy for when things go wrong. 319 00:32:45,740 --> 00:32:53,930 And thirdly, you really need sort of the technological innovation, because as we've seen child designs with diagnostics and with vaccines. 320 00:32:53,930 --> 00:32:59,030 If you put in place those technologies that are broadly applicable across a whole range of threats, 321 00:32:59,030 --> 00:33:03,350 then you're already ahead of the game where you threat arises. 322 00:33:03,350 --> 00:33:11,920 I think the UK has done an extremely good job in terms of research and research, the impacts in the cockpit 19 pandemic, and that is recognised. 323 00:33:11,920 --> 00:33:15,080 I think that's recognised at all levels, both within the research community, 324 00:33:15,080 --> 00:33:19,720 within the leaders of Oxford University and other universities and within government. 325 00:33:19,720 --> 00:33:24,740 And so I do believe we're very well-placed and I'm hoping that we will see in the next few years a real 326 00:33:24,740 --> 00:33:30,860 consolidation and will all of what we've learnt to put us in a much better place to make to a safer world. 327 00:33:30,860 --> 00:33:39,200 However, Peter was very keen to emphasise that there are serious obstacles to our preparing for the next pandemic, whatever that may be. 328 00:33:39,200 --> 00:33:43,780 One of the dangers is always fighting the last war. 329 00:33:43,780 --> 00:33:52,190 And that's something I've observed over the years, is that the planning around response to Bursley was based on what happened in Salz and then 330 00:33:52,190 --> 00:33:57,500 the planning and response to the next flu pandemic was based on the experience with bird flu. 331 00:33:57,500 --> 00:34:02,300 And then the planning for Cobbett, 19, was based on the 2009 flu pandemic. 332 00:34:02,300 --> 00:34:05,900 So you have to be very wary about thinking that you know what's coming. 333 00:34:05,900 --> 00:34:11,090 It's very likely that we'll have some knowledge about an emerging virus to be 334 00:34:11,090 --> 00:34:15,290 from a class of viruses that we probably know about and we'll know a little bit. 335 00:34:15,290 --> 00:34:20,150 But it's very likely it will be a new variant of that virus, which will behave in a different way. 336 00:34:20,150 --> 00:34:27,380 Covered 19 is a good example. It's a corona virus and there are seasonal corona viruses that have been around and known about for many years. 337 00:34:27,380 --> 00:34:34,640 And then there's the Middle East Respiratory Corona virus, which has been around for some time, is much more severe and comes from animals. 338 00:34:34,640 --> 00:34:39,350 And we know about that. Now, this is in that same class, but it behaves differently. 339 00:34:39,350 --> 00:34:46,400 It's much more transmissible than most corona virus and it's more severe than seasonal corona viruses. 340 00:34:46,400 --> 00:34:53,450 And it has a different pattern of disease in terms of when the peak infectivity is different from sovs. 341 00:34:53,450 --> 00:34:58,250 When the patients develop an inflammatory syndrome, it's like other coronaviruses. 342 00:34:58,250 --> 00:35:02,960 So it'll be something we know something about, but there'll be many different aspects of it. 343 00:35:02,960 --> 00:35:10,310 And we have to be very careful not to make assumptions because it's from a class of viruses we've seen before that we've got to know how behaves and 344 00:35:10,310 --> 00:35:21,320 corona viruses had already been identified as a serious risk prior to our current pandemic converter boxes were on the WHL list of priority pathogens. 345 00:35:21,320 --> 00:35:25,880 So they were identified as a risk. So we got that right. 346 00:35:25,880 --> 00:35:32,750 What is new about the viruses that just have a slightly different genetic makeup in slightly different biology, 347 00:35:32,750 --> 00:35:38,150 which means that you have to rethink your suite of interventions, so you have to rethink your diagnostics. 348 00:35:38,150 --> 00:35:41,960 You have to rethink your drugs and vaccines cetera. The vaccines failed. 349 00:35:41,960 --> 00:35:48,740 As we've seen with clearly recent results of success in the cloning of our state, things was reasonably well advanced. 350 00:35:48,740 --> 00:35:55,790 And there had been work ongoing to develop vaccine constructs for the Middle East Respiratory corona virus and to the source coronavirus. 351 00:35:55,790 --> 00:36:02,240 So in that sense, that worked. We have the platform technologies up to be able to switch to a new corona virus. 352 00:36:02,240 --> 00:36:10,070 I think we did less well on drugs. What we didn't have was a suite of products that we thought were active against corona viruses. 353 00:36:10,070 --> 00:36:19,070 And we're ready to go into clinical trials. There were some very preliminary data from experience of trying medicines during the first 354 00:36:19,070 --> 00:36:24,170 signs outbreak that really there was nothing in that suite of drugs that was very spectacular. 355 00:36:24,170 --> 00:36:31,910 So we were left with starting out the clinical trials with rather unpromising drugs to end our conversation. 356 00:36:31,910 --> 00:36:36,440 I mentioned my discussion with Professor Brian Angus comparing Kovik, 19, 357 00:36:36,440 --> 00:36:43,310 to other diseases like Ebola and asked Peter which diseases concerns him most. 358 00:36:43,310 --> 00:36:45,800 The answer very much depends on what perspective you're taking. 359 00:36:45,800 --> 00:36:51,530 If you're taking a personal perspective about whether you would pick about a virus or corona virus if you had to. 360 00:36:51,530 --> 00:37:00,260 One of the two, I think the answer's pretty clear. But in terms of the global health impact, then I'm much more scared of things like corona viruses. 361 00:37:00,260 --> 00:37:06,080 But many other categories of viruses are common or garden, but have the potential to become more serious. 362 00:37:06,080 --> 00:37:12,740 Examples are much more serious strains of influenza, but there are also other viruses like enteroviruses, which are very common. 363 00:37:12,740 --> 00:37:16,070 What viruses that cause polio accentuate a new strain of something like that? 364 00:37:16,070 --> 00:37:20,830 Those viruses really could have a huge impact and we've seen that with this pandemic. 365 00:37:20,830 --> 00:37:24,680 And so it's not just about the severity of a single infection. 366 00:37:24,680 --> 00:37:31,580 It's about a whole package of how that virus transmits itself and the impact it has beyond the individual health. 367 00:37:31,580 --> 00:37:39,050 Our next guest has, like Peter, played a huge role in the global fight back against the Kovik 19 pandemic. 368 00:37:39,050 --> 00:37:48,140 It was a real privilege to talk to Sara Gilbert, professor of vaccinology at Oxford, particularly at such a busy time for her. 369 00:37:48,140 --> 00:38:00,650 Sarah has been rightly hailed as a pioneer of Oxford's Chad Ox, one in KOF 19 Corona virus vaccine, but her work in this area started a long time ago. 370 00:38:00,650 --> 00:38:10,190 I began by asking her when she first got involved. I started working on vaccines because Adrian Hale wanted to make a vaccine against malaria. 371 00:38:10,190 --> 00:38:13,820 That in particular that works for inducing strong t cell responses. 372 00:38:13,820 --> 00:38:18,560 And we've heard quite a bit this year about T cell responses as well as antibody responses. 373 00:38:18,560 --> 00:38:25,430 But remember that most of the vaccines that we use that are licenced today, we only think about the antibody responses that they induce. 374 00:38:25,430 --> 00:38:30,950 They usually work through antibody responses and to find out if they all work and we measure antibody responses. 375 00:38:30,950 --> 00:38:38,420 And so responses are important, but they're not at the forefront of what people were thinking about at the time when making a vaccine. 376 00:38:38,420 --> 00:38:46,730 But there's a particular stage in the malaria lifecycle where shortly after somebody has been bitten by an infected mosquito, 377 00:38:46,730 --> 00:38:54,500 the parasites that go into their bloodstream, which called, oh, it's at that stage very, very quickly get inside the liver in small numbers. 378 00:38:54,500 --> 00:38:58,670 There's only maybe 10 infected cells if if even that. 379 00:38:58,670 --> 00:39:01,090 So it's not a particular problem for the liver, 380 00:39:01,090 --> 00:39:06,320 but there will be a few infected liver cells as far as the whites turn into factories to make lots more 381 00:39:06,320 --> 00:39:11,600 of themselves in a similar way to a virus is taken over cells in our body and turn them into factories. 382 00:39:11,600 --> 00:39:15,070 That's what the malaria parasite does at that stage of the lifecycle in the liver. 383 00:39:15,070 --> 00:39:21,350 And because they're hidden away inside a liver cell and they stay there for about a week, antibodies can't reach them. 384 00:39:21,350 --> 00:39:25,340 So antibodies, if you have a very high level of antibodies in your blood, 385 00:39:25,340 --> 00:39:31,340 when the mosquito bites you and the antibodies can recognise as far as away and destroy it, then you won't get malaria. 386 00:39:31,340 --> 00:39:34,580 But there's a very short time. That's only about an hour. 387 00:39:34,580 --> 00:39:39,920 And so there's not really very much chance of that working, whereas the parasites then inside the liver, 388 00:39:39,920 --> 00:39:43,910 sitting inside a cell, making more itself for about a week. 389 00:39:43,910 --> 00:39:47,030 And T cells can recognise those infected liver cells and destroy them. 390 00:39:47,030 --> 00:39:54,590 And that does happen in people who live in malaria endemic areas and have done all their lives and they have some natural immunity to malaria. 391 00:39:54,590 --> 00:40:00,050 Then there is quite a bit of evidence that sometimes the parasite can be attacked at that stage of the lifecycle. 392 00:40:00,050 --> 00:40:07,610 So the idea would be to develop a vaccine that would induce cell responses that would kill these infected liver cells. 393 00:40:07,610 --> 00:40:10,730 Again, small number. So it's not going to cause a lot of liver damage. 394 00:40:10,730 --> 00:40:14,900 And then the person who'd been infected wouldn't become ill at all because you don't become ill 395 00:40:14,900 --> 00:40:19,400 until some days after the parasite comes out of the liver and starts infecting red blood cells. 396 00:40:19,400 --> 00:40:23,060 And then it starts to really multiply to high numbers in the blood level. 397 00:40:23,060 --> 00:40:30,380 And that's when you see people getting fevers. So all of that could be prevented if we could have a TSL inducing vaccine. 398 00:40:30,380 --> 00:40:37,220 And adenoviruses are really effective ways of making a good Tiso response when you vaccinate somebody. 399 00:40:37,220 --> 00:40:40,220 And so are some other viruses called pox viruses. 400 00:40:40,220 --> 00:40:46,430 So pox viruses are relatives of smallpox and vaccine, a virus that Edward Jenner used against smallpox. 401 00:40:46,430 --> 00:40:50,720 And there's a safer version of the vaccine, your virus. 402 00:40:50,720 --> 00:40:55,740 So the vaccine is a virus that is derived from the vaccine that Edward Gennie used. 403 00:40:55,740 --> 00:41:00,290 And there are some important differences that we don't really need to go into. But they're not the same. 404 00:41:00,290 --> 00:41:04,880 But that vaccine does actually spread through the body when you use it to vaccinate somebody with. 405 00:41:04,880 --> 00:41:08,300 And if somebody has a very weak immune system, it can actually be dangerous. 406 00:41:08,300 --> 00:41:14,480 But we use a replication deficient version of a pox virus like our replication deficient adenovirus. 407 00:41:14,480 --> 00:41:23,540 We have a replication deficient pox virus is called MBA, a modified vaccine virus, Ankara, and that is not able to spread through the body. 408 00:41:23,540 --> 00:41:31,580 When you vaccinate somebody in a very similar way to the adenovirus, you can add genes into it from different pathogens. 409 00:41:31,580 --> 00:41:34,010 And those genes are expressed at high levels. 410 00:41:34,010 --> 00:41:40,910 When you vaccinate somebody and you get a good immune response and the strongest TSA response is that could be generated, 411 00:41:40,910 --> 00:41:49,670 we found were from giving somebody an adenovirus carrying a malaria antigen and then following it four to eight weeks later with a pox virus, 412 00:41:49,670 --> 00:41:51,710 the MBA carrying malaria antigen. 413 00:41:51,710 --> 00:41:58,400 So they're both very safe to use because they can't spread through the body, both expressing the same malaria antigen. 414 00:41:58,400 --> 00:42:04,070 And if you use them in that sequence or actually you can reverse the order, it's not too important, which comes first. 415 00:42:04,070 --> 00:42:10,490 You get a really strong T cell response. The TSA response is actually stronger with the adenovirus than with the NBA. 416 00:42:10,490 --> 00:42:15,780 But it doesn't matter which way round you give them, you come to the same very high t cell response in the end. 417 00:42:15,780 --> 00:42:21,470 I worked on that technology and that's when we started being interested in using simian adenoviruses rather 418 00:42:21,470 --> 00:42:27,230 than human adenoviruses because of the problem of pre-existing immunity to human and viruses in humans. 419 00:42:27,230 --> 00:42:28,910 We knew that was going to be a problem. 420 00:42:28,910 --> 00:42:35,900 And although in the lab the human adenoviruses make great vaccines, it wasn't something we want to take into clinical trials. 421 00:42:35,900 --> 00:42:42,350 So we had to wait until we got a collaboration with somebody else who'd got a simian adenoviruses that we could use. 422 00:42:42,350 --> 00:42:47,630 And that's when we started doing clinical trials for the malaria vaccine. But these are very adaptable, technical. 423 00:42:47,630 --> 00:42:51,660 These other people were using them to make therapeutic of vaccines. 424 00:42:51,660 --> 00:43:01,170 It's possible to put antigens into them. Take him from lots of different pathogens, bacteria as well as viruses, and use them alone or in combination. 425 00:43:01,170 --> 00:43:05,520 And it was designed to be very adaptable technology. 426 00:43:05,520 --> 00:43:10,780 And they do induce good antibody responses as well as the strong T cell responses. 427 00:43:10,780 --> 00:43:15,420 And I then started working on influenza vaccines again, thinking about the T cell response, 428 00:43:15,420 --> 00:43:23,670 because the antigens that we make is our response to from the flu virus unless variable than the ones that we make an antibody response to. 429 00:43:23,670 --> 00:43:28,950 So there's a better chance of having broader protection. And that's a project that I worked on for a while. 430 00:43:28,950 --> 00:43:33,090 Haven't really brought that to a conclusion yet. I still have a flu project running at the moment. 431 00:43:33,090 --> 00:43:38,340 And with that, we're now exploring different routes of administering the vaccines because 432 00:43:38,340 --> 00:43:42,570 it may be more effective not to give the vaccines I intramuscular injection, 433 00:43:42,570 --> 00:43:45,780 but to get them into the respiratory tract directly. 434 00:43:45,780 --> 00:43:54,750 And that's particularly important for flu because the disease onset is very rapid for flu virus 48 hours after you've been exposed to the virus. 435 00:43:54,750 --> 00:43:58,100 That's when symptoms peak. And that's a really short space of time. 436 00:43:58,100 --> 00:44:06,060 Whereas for corona viruses of many other viruses, it takes longer for the symptoms to really onset after a person has been exposed to the virus. 437 00:44:06,060 --> 00:44:12,090 So if the T cells and the antibodies have to move to a different part of the body, that's a bit more time in most cases. 438 00:44:12,090 --> 00:44:17,870 But that's not true in flu. It needs a really rapid response to the incoming infection. 439 00:44:17,870 --> 00:44:23,300 Sarah has also done a huge amount of work on the subject of this episode, Disease X. 440 00:44:23,300 --> 00:44:31,430 And I asked her to tell me more about what kind of pathogen this might turn out to be and what we should perhaps fear most. 441 00:44:31,430 --> 00:44:34,490 So for people think about disease X, it's just the unknown. 442 00:44:34,490 --> 00:44:38,480 We don't know where it's going to come from or what it's going to be, but there will be something. 443 00:44:38,480 --> 00:44:42,350 The world had been halfheartedly preparing for a flu pandemic for quite a long time. 444 00:44:42,350 --> 00:44:45,770 And then we got a corona virus pandemic. So we weren't expecting that. 445 00:44:45,770 --> 00:44:49,430 But actually, the people who study these things would have said that we should have been expecting 446 00:44:49,430 --> 00:44:53,930 that because we've seen corona virus outbreaks before and we know what they can do. 447 00:44:53,930 --> 00:44:57,950 So we shouldn't have been surprised. What else is going to surprise us? 448 00:44:57,950 --> 00:45:03,470 We don't know. That's why we call it disease X. But the one that I'm most worried about, it's still flu because flu is still out there. 449 00:45:03,470 --> 00:45:09,140 There are so many different versions of flu in bird populations. We have no idea what they are, where they are. 450 00:45:09,140 --> 00:45:16,040 Maybe it mutates really rapidly. And when people get infected, the onset of the disease is very, very rapid. 451 00:45:16,040 --> 00:45:20,390 So there's not much time to do anything before the symptoms take hold. 452 00:45:20,390 --> 00:45:26,990 So a flu pandemic like the 1918 flu could still be absolutely devastating today. 453 00:45:26,990 --> 00:45:33,650 Studying and preparing for a coming disease X has been central to much of Sarah's recent work. 454 00:45:33,650 --> 00:45:42,280 So I was interested to hear what she was working on when this was added to the World Health Organisation's list of blueprint priority diseases. 455 00:45:42,280 --> 00:45:46,960 At the time that Disease X was added to the WTO list of priority pathogens, 456 00:45:46,960 --> 00:45:52,430 I was already working on vaccines for a number of other priority pathogens which are on the list. 457 00:45:52,430 --> 00:46:00,700 Meurs, NIPA and Lassa, three very different viruses, but all capable of causing outbreaks in different parts of the world with different outcomes. 458 00:46:00,700 --> 00:46:07,540 But we need a vaccine against all of them. Another one coming in Congo haemorrhagic fever and colleagues of mine were also 459 00:46:07,540 --> 00:46:11,680 working on vaccines against Rift Valley fever virus and chikungunya virus. 460 00:46:11,680 --> 00:46:15,970 Also outbreak pathogens which cause outbreaks in different parts of the world. 461 00:46:15,970 --> 00:46:23,620 And so we have settled on using the Cherrix one platform technology for all of these different outbreak diseases, 462 00:46:23,620 --> 00:46:29,500 because it's a technology that's very adaptable. We can use it to make vaccines in lots of different ways. 463 00:46:29,500 --> 00:46:32,800 And we know how to manufacture it. We know that it's safe to use. 464 00:46:32,800 --> 00:46:40,870 We know that it induces the kind of immune response that we want to see in a vaccine and doesn't need very low temperature situation and is therefore, 465 00:46:40,870 --> 00:46:47,170 in theory, suitable for use in many different parts of the world. So a lot of those different programmes were going on. 466 00:46:47,170 --> 00:46:51,610 But the early parts of each of those programmes took several years to get started. 467 00:46:51,610 --> 00:46:55,720 And when Doli Recto introduce a concept of disease X, 468 00:46:55,720 --> 00:47:02,290 we have to start thinking about how could we get from the knowledge of a new disease to having a vaccine 469 00:47:02,290 --> 00:47:07,210 that we could vaccinate people with in a clinical trial much more quickly than we have been doing. 470 00:47:07,210 --> 00:47:13,570 And to be honest, there weren't really any particular technical hurdles that we were going to need to overcome. 471 00:47:13,570 --> 00:47:17,080 It was more a question of rethinking the way that we did things. 472 00:47:17,080 --> 00:47:24,010 The order that we did things in doing more things in parallel, which is a concept that lots of people have become familiar with this year, 473 00:47:24,010 --> 00:47:27,880 instead of just thinking that we had a small amount of money. 474 00:47:27,880 --> 00:47:32,890 And so we make a vaccine and just test it in the lab and then think about moving on later. 475 00:47:32,890 --> 00:47:41,770 We started thinking about the prospect that we might be finding out about a new virus and would need to get into clinical testing really quickly. 476 00:47:41,770 --> 00:47:44,140 So what would be our approach to that? 477 00:47:44,140 --> 00:47:50,920 For some of the grant applications that I'd applied for, there was the opportunity to include what's called a demonstration project. 478 00:47:50,920 --> 00:47:55,810 So part of the process will be to demonstrate that the technologies works as a vaccine. 479 00:47:55,810 --> 00:48:01,870 But then you would have a demonstration project where you would ask somebody else to nominate a sequence that you didn't know what it is 480 00:48:01,870 --> 00:48:09,250 going to be and then see how quickly you could go through making a vaccine and get it to a particular point in vaccine manufacturing, 481 00:48:09,250 --> 00:48:15,100 for example. And so we thought about how we would go through that and what would be a good disease to do it with. 482 00:48:15,100 --> 00:48:19,720 And I've been thinking of influenza antigens because there are new ones occurring all the time. 483 00:48:19,720 --> 00:48:27,310 And it would be possible to ask somebody as a kind of test run to nominate a new influenza antigen that only just been identified. 484 00:48:27,310 --> 00:48:34,290 That exact sequence. And then we could put it into a vaccine and see how fast we could get through the manufacturing process. 485 00:48:34,290 --> 00:48:39,670 And we would have been able to demonstrate that we couldn't have started before, particularly like the sequence wasn't known. 486 00:48:39,670 --> 00:48:47,890 And so when a new pathogen like Sarkozy to arise is that SoftLayer brilliant demonstration project because nobody knew what it was before. 487 00:48:47,890 --> 00:48:54,130 So thinking about and wanting to test the technology, not knowing if we'd actually need to use the vaccine, 488 00:48:54,130 --> 00:48:59,200 but anyway wanting to see how quickly we could make a vaccine to start the process. 489 00:48:59,200 --> 00:49:04,900 This was an ideal candidate. The story of Sarah and the rest of the teams work on Coupet, 19, 490 00:49:04,900 --> 00:49:11,110 is definitely one for another podcast, which I hope we'll make in the not too distant future. 491 00:49:11,110 --> 00:49:16,620 For now, though, I was keen to find out whether Sarah was already reflecting on those efforts. 492 00:49:16,620 --> 00:49:19,300 There's quite a lot of things I think we could do better next time. 493 00:49:19,300 --> 00:49:26,050 One is that we've been advocating for better manufacturing facilities so that we can get the vaccines made into clinical trials. 494 00:49:26,050 --> 00:49:27,970 And that hasn't happened yet. 495 00:49:27,970 --> 00:49:34,690 The vaccines manufacturing, the innovation centre had been funded and the building had started to be built, but it wasn't ready to use. 496 00:49:34,690 --> 00:49:39,880 So it wasn't any use to us on our own manufacturing centre, the clinical bio manufacturing facility. 497 00:49:39,880 --> 00:49:44,440 We've been trying to get that extended and upgraded for years as well, and there's been no money to do that. 498 00:49:44,440 --> 00:49:49,540 We really want to be able to go much more quickly with more candidates as well. 499 00:49:49,540 --> 00:49:54,250 So one thing that we had to deal with this year is that we had one choice for the vaccine. 500 00:49:54,250 --> 00:49:59,320 There was no opportunity to try to make two or three different versions of the vaccine and then 501 00:49:59,320 --> 00:50:03,490 decide which one we wanted to take into clinical trials because we only have one clean room. 502 00:50:03,490 --> 00:50:08,800 So it had to be one shot from the beginning. That's why we only made one subsequently. 503 00:50:08,800 --> 00:50:13,870 We made some different versions in the lab and we've tested them and we're still happy with what we started out with. 504 00:50:13,870 --> 00:50:17,260 It would have been good and in some cases for different viruses, 505 00:50:17,260 --> 00:50:22,600 it would have been more important to be able to start off with making maybe up to five different versions 506 00:50:22,600 --> 00:50:27,940 of a vaccine at the early stages until we get some preliminary work done with it and then select. 507 00:50:27,940 --> 00:50:35,520 But we knew we couldn't do that this year. So bigger, better, more available manufacturing facilities is one thing. 508 00:50:35,520 --> 00:50:39,680 Then we have to think about the testing in animal models that we did. 509 00:50:39,680 --> 00:50:46,070 We were required to demonstrate that we weren't going to cause a phenomenon known as vaccine enhanced disease, 510 00:50:46,070 --> 00:50:49,790 which is something that's been seen in some vaccines in the last century. 511 00:50:49,790 --> 00:50:54,020 There was a respiratory Sin City ill vaccine that was tested in children, 512 00:50:54,020 --> 00:50:58,790 and it did actually make the disease worse when the children then got exposed to the virus. 513 00:50:58,790 --> 00:51:04,760 And understanding that that was not going to happen this year, that the vaccines that we were making was really important. 514 00:51:04,760 --> 00:51:10,640 And we think that we already understood it. And we know what kind of immune response was responsible for the enhanced disease. 515 00:51:10,640 --> 00:51:15,560 And that's not the kind of immune response we get with this technology. But we still had to demonstrate it. 516 00:51:15,560 --> 00:51:20,870 And that takes time because you can't demonstrate it with animal models until there is an animal model. 517 00:51:20,870 --> 00:51:28,310 And that will have to be done very quickly. And I think I would like to put a bit more effort into just really understanding the immune 518 00:51:28,310 --> 00:51:33,980 responses that we get from different vaccination technologies so that we are not having to cheque, 519 00:51:33,980 --> 00:51:37,670 that we're not going to get vaccine enhanced disease because we are absolutely certain 520 00:51:37,670 --> 00:51:41,570 that we won't with these technologies that would enable us to go faster as well. 521 00:51:41,570 --> 00:51:46,670 And then there's things that I think we learnt after Ebola on clinical trial design. 522 00:51:46,670 --> 00:51:51,620 So in the Ebola outbreak, there were vaccines that were ready to go into efficacy trials, 523 00:51:51,620 --> 00:51:57,770 but nobody could agree on how those efficacy trials should be set up and whether it should be a placebo controlled trial, 524 00:51:57,770 --> 00:52:04,250 because it was thought that wasn't going to be ethical. And in the end, after enormous amount of discussion and months and months, months of delay, 525 00:52:04,250 --> 00:52:08,150 we had a ring vaccination trial with either immediate or delayed vaccination. 526 00:52:08,150 --> 00:52:12,240 So some people in the delayed vaccination group who had to wait three weeks for that 527 00:52:12,240 --> 00:52:17,730 vaccine did contract Ebola during the time they were waiting for their Ebola vaccine. 528 00:52:17,730 --> 00:52:25,280 But it's necessary in any efficacy study that some people are going to get infected with the disease in order to know that the vaccine works. 529 00:52:25,280 --> 00:52:28,940 And when you think back to the idea of a placebo controlled trial, 530 00:52:28,940 --> 00:52:33,260 which horrified everybody because it wouldn't be ethical, because some people wouldn't be vaccinated, 531 00:52:33,260 --> 00:52:37,340 it's actually not really very different doing a delayed vaccination trial in which some 532 00:52:37,340 --> 00:52:42,200 people will be impacted because they haven't received the vaccine until later on. 533 00:52:42,200 --> 00:52:48,650 So thinking about child designs, particularly for viruses with a high fatality rate. 534 00:52:48,650 --> 00:52:54,350 So Kobe, it doesn't have a very high fatality rate. It spread so rapidly, it causes major disruption. 535 00:52:54,350 --> 00:53:00,500 But actually, the percentage of people who die from it is much lower than Ebola and many of the other outbreak pathogens. 536 00:53:00,500 --> 00:53:03,680 So we probably still haven't really addressed the point of how should we test 537 00:53:03,680 --> 00:53:07,460 the efficacy of a vaccine against a virus that does have a high fatality rate. 538 00:53:07,460 --> 00:53:10,880 And that's something that probably requires more discussion and modelling and 539 00:53:10,880 --> 00:53:14,850 better planning so that we would be ready in the future to do that kind of thing. 540 00:53:14,850 --> 00:53:16,670 Well, what's worked really well this year, I think, 541 00:53:16,670 --> 00:53:24,170 has been the collaboration's within the university with AstraZeneca between different companies, with lots of different academic collaborators. 542 00:53:24,170 --> 00:53:25,430 That's all been really good. 543 00:53:25,430 --> 00:53:31,340 And I hope that will continue in the future because without that kind of collaboration, nobody can make progress as quickly. 544 00:53:31,340 --> 00:53:35,770 So we need to see a lot more of that before our conversation ended. 545 00:53:35,770 --> 00:53:45,170 Sarah and I got onto the theme of this season, the broad history of pandemics and the role of one man in particular, Edward Jenner. 546 00:53:45,170 --> 00:53:53,320 I'm including it here because Sarah has a unique and fascinating perspective on his achievements and how it relates to her work today. 547 00:53:53,320 --> 00:54:01,250 A lot of similarities in what Janet did and what we do today. One of the things that he did on a very small scale was the challenge experiment. 548 00:54:01,250 --> 00:54:06,460 So he didn't just give somebody a vaccine and then say, well, they're fine, obviously. 549 00:54:06,460 --> 00:54:13,550 So I vaccinated them. They'll be protected. Now, he vaccinated his gardener's son with the cowpox, and then he did it, 550 00:54:13,550 --> 00:54:18,320 deliberately exposed the boy to smallpox and showed that he wasn't infected with smallpox. 551 00:54:18,320 --> 00:54:19,850 That sounds horrendous, 552 00:54:19,850 --> 00:54:28,160 but that was done because actually exposure to low amounts of smallpox was the way at the time that people were being protected against smallpox. 553 00:54:28,160 --> 00:54:35,690 So smallpox, if you had an outbreak coming through a particular area, one in three of the children would be killed by smallpox. 554 00:54:35,690 --> 00:54:42,470 And people were using let's called Barry relation, which is deliberate infection with a small amount of the smallpox virus, 555 00:54:42,470 --> 00:54:48,650 because that was known to protect people against smallpox infection. And apparently, Janet had this done to himself as a child. 556 00:54:48,650 --> 00:54:52,610 And it was pretty horrendous process, partly because they didn't really understand how it worked. 557 00:54:52,610 --> 00:54:56,420 So the children were kept in the dark on a very poor diet while this was happening. 558 00:54:56,420 --> 00:55:00,770 It was meant to be stopping the virus from having the power to take over the child. 559 00:55:00,770 --> 00:55:03,490 She probably just made the child more likely to be very ill. 560 00:55:03,490 --> 00:55:09,290 The death rate from vaccination was about one in 50, which sounds terrible, but it was much better than one in three. 561 00:55:09,290 --> 00:55:13,880 And then Jana wanted to replace very lation with something much safer. 562 00:55:13,880 --> 00:55:20,840 And the death rate from vaccination against smallpox with this live replication competent vaccine here is about one in a million. 563 00:55:20,840 --> 00:55:24,770 So, again, we wouldn't use a vaccine like that today. That's far too dangerous. 564 00:55:24,770 --> 00:55:29,660 But it was so much better than one in 50 with Barry elation or one in three with smallpox infection. 565 00:55:29,660 --> 00:55:34,010 So it was all about reducing the risk continually. And that's always something we're looking to do. 566 00:55:34,010 --> 00:55:39,350 However safe something is, we're always looking at any possibility to reduce the risk even further. 567 00:55:39,350 --> 00:55:49,040 So when he exposed his Goldman son, James Facts to smallpox, he was being put through the normal process of exposure to a small amount of smallpox. 568 00:55:49,040 --> 00:55:55,370 But it didn't take he didn't get any kind of infection at all, whereas other children would have had an infection, been quite ill and then recovered. 569 00:55:55,370 --> 00:55:58,460 Hopefully at least 49 out of 50 of them did. 570 00:55:58,460 --> 00:56:05,420 And then they would have been immune to smallpox and not satisfied by doing this once he did it a second time and the violation still didn't take. 571 00:56:05,420 --> 00:56:08,960 So James Phipps is known to be immune to smallpox. 572 00:56:08,960 --> 00:56:18,170 So the idea of vaccinating and then testing efficacy, which in the time of Kobrick we're doing with very large phase three trials, 573 00:56:18,170 --> 00:56:25,130 waiting to see if people who got the vaccine or got a control vaccine get infected with COPD is still the same concept. 574 00:56:25,130 --> 00:56:32,450 You have to test to see if the vaccine works and not just give the vaccine and say that it must work because you vaccinated somebody. 575 00:56:32,450 --> 00:56:38,930 And then the other thing that Janet did that was absolutely huge. And that does, I think, have a lot of bearing on what we do now. 576 00:56:38,930 --> 00:56:44,840 Is he communicated his findings. He wasn't the first person to use cowpox to protect against smallpox. 577 00:56:44,840 --> 00:56:50,690 Other people have done it before. They are quite a few records of it happening. But what he did was having done his experiments. 578 00:56:50,690 --> 00:56:54,110 He went to the world society and gave a presentation. 579 00:56:54,110 --> 00:57:02,780 And then he continued to talk about it and he continued to vaccinate large numbers of people and promoted the cause of vaccination, 580 00:57:02,780 --> 00:57:07,100 eventually managed to get very chelation. The exposure to smallpox. He got that outlawed. 581 00:57:07,100 --> 00:57:11,910 So he was very vocal about what he was doing and why it was important. 582 00:57:11,910 --> 00:57:15,260 And I think that's something that scientists often don't really want to do. 583 00:57:15,260 --> 00:57:20,120 We want to get on with the science that we have to follow in Dennis footsteps in that way as well, 584 00:57:20,120 --> 00:57:24,230 and communicate the findings and be clear about what it is that we've done. 585 00:57:24,230 --> 00:57:30,470 But make sure that everybody knows about it and understands it, because if they don't understand it, then there won't be any impact. 586 00:57:30,470 --> 00:57:40,830 This if we come up with a fantastic discovery in a lab and don't really tell anybody, it's not going to make any difference. 587 00:57:40,830 --> 00:57:46,230 The next voice is your. Here are two you may recognise from earlier in the series. 588 00:57:46,230 --> 00:57:54,860 The first of these is Professor Jemmy Whitworth from the London School of Hygiene and Tropical Medicine, whom we met in Episode nine. 589 00:57:54,860 --> 00:58:04,890 You're about to join us midway through a conversation about plague and the potential threat of anti-microbial resistance. 590 00:58:04,890 --> 00:58:08,640 Now, it's a bacterial infection, as I've mentioned. 591 00:58:08,640 --> 00:58:18,870 And so it is treatable with antibiotics and in fact, it's it's pretty sensitive to some standard antibiotics. 592 00:58:18,870 --> 00:58:30,000 So as long as you have a level of suspicion that you identify cases of plague and that people present early enough in the course of their infection, 593 00:58:30,000 --> 00:58:31,860 they should be eminently treatable. 594 00:58:31,860 --> 00:58:39,420 It's not like the situation historically where vast numbers of people died and there was nothing that could be done about these days. 595 00:58:39,420 --> 00:58:43,770 Once you know that there is plague in an area and you're alert to it, 596 00:58:43,770 --> 00:58:49,980 then as long as you can see those cases quickly and get them onto treatment, then they should do very well. 597 00:58:49,980 --> 00:58:54,870 The vast majority will recover from plague with antibiotics. 598 00:58:54,870 --> 00:59:00,840 Anti-Microbial resistance is a problem for plague, as it is for many other conditions. 599 00:59:00,840 --> 00:59:06,630 There is some suggestion from the Madagascar outbreak that there might have been some development 600 00:59:06,630 --> 00:59:13,200 of anti-microbial resistance that made the antibiotics not as successful as we've seen previously. 601 00:59:13,200 --> 00:59:16,710 That's certainly something that needs to be kept an eye on. 602 00:59:16,710 --> 00:59:26,990 And all around the world, there are problems with the development of antibiotic resistance, which makes diseases much harder to treat, 603 00:59:26,990 --> 00:59:35,550 and that we are reaching a situation where for some conditions, they are becoming close to untreatable. 604 00:59:35,550 --> 00:59:40,290 I don't think we've reached that really for any diseases yet. 605 00:59:40,290 --> 00:59:44,490 What for? Conditions even such as gonorrhoea, for example. 606 00:59:44,490 --> 00:59:52,440 High level of antibiotic resistance means that there is a looming possibility that some infections 607 00:59:52,440 --> 00:59:58,290 which have been treatable in the past might become essentially untreatable in the future. 608 00:59:58,290 --> 01:00:04,260 Having said that, that's thinking to the future. And I think we do need to keep that in mind. 609 01:00:04,260 --> 01:00:10,410 But at present, the major problem with antibiotics is lack of access to. 610 01:00:10,410 --> 01:00:20,100 So there are currently many more deaths that occur because of lack of access to antibiotics and because of antibiotic resistance, particularly, 611 01:00:20,100 --> 01:00:31,050 of course, that is in low resource settings in poor countries, particularly those which have limited access to health services and so on. 612 01:00:31,050 --> 01:00:39,210 So I think it's important that the message is that we need to reduce inappropriate antibiotic use. 613 01:00:39,210 --> 01:00:50,940 It's not that we should reduce all antibiotic use because we're in a situation, a global situation where we don't have adequate access to antibiotics. 614 01:00:50,940 --> 01:00:59,430 So it's important that the message is appreciated as reducing inappropriate antibiotic use later on in our conversation. 615 01:00:59,430 --> 01:01:08,760 Jemmy also had a warning about the ways in which one of the other major threats facing humanity, climate change could impact on the spread of disease. 616 01:01:08,760 --> 01:01:23,190 One of the issues, recent trends that we've seen is that with climate change, the endemic range of a number of infectious diseases has increased. 617 01:01:23,190 --> 01:01:33,750 And this is because as temperatures rise, that means that insect vectors, particularly mosquitoes, are able to expand their range. 618 01:01:33,750 --> 01:01:44,070 We've seen this in recent times in Europe, where conditions such as Denki, but also Chicken Gunya, 619 01:01:44,070 --> 01:01:51,030 even Zika, have started to transmit during summer months within southern Europe. 620 01:01:51,030 --> 01:02:00,000 And you can see the march of the range of the mosquitoes steadily moving north over time. 621 01:02:00,000 --> 01:02:09,660 And this starts to threaten major centres of population, places like Paris or Amsterdam or even London and so on, 622 01:02:09,660 --> 01:02:13,680 in the future that these diseases will start to spread. 623 01:02:13,680 --> 01:02:22,800 We're already seeing that EDI's mosquitoes, particularly Aedes albopictus, so-called Asian tiger mosquito, 624 01:02:22,800 --> 01:02:29,550 is a fact of life in Spain and Italy in a way that it was not seen before. 625 01:02:29,550 --> 01:02:35,130 So these mosquitoes have established themselves in places where they were not before, 626 01:02:35,130 --> 01:02:39,810 and that means that epidemic diseases are occurring more frequently. 627 01:02:39,810 --> 01:02:46,410 So we are seeing outbreaks of West Nile fever, diseases like Crimea, 628 01:02:46,410 --> 01:02:55,140 Congo haemorrhagic fever occurring in Europe in larger numbers and over wider areas than we have seen before. 629 01:02:55,140 --> 01:03:04,370 And that means that public health authorities need to be aware that these diseases are on the march and they need to have. 630 01:03:04,370 --> 01:03:09,800 Control measures in place to be able to deal with them when they occur. 631 01:03:09,800 --> 01:03:15,770 And for countries like the UK where they have not yet arrived, but they are threatened, 632 01:03:15,770 --> 01:03:21,710 then we need to have very good surveillance systems in place so that we can identify when they occur. 633 01:03:21,710 --> 01:03:28,430 Because if you have just a few of the mosquitoes that are relevant for this, 634 01:03:28,430 --> 01:03:36,890 that's a much easier situation to be able to control and eliminate that focus than if you wait until it is well established. 635 01:03:36,890 --> 01:03:46,190 We do need to think about novel infections and particularly zoonotic infections, those that affect largely animals, 636 01:03:46,190 --> 01:03:58,580 but that could pass on into the human population with global warming, with population increase moving into forested areas and so on. 637 01:03:58,580 --> 01:04:04,520 We do come into contact more with zoonotic diseases than we do in the past. 638 01:04:04,520 --> 01:04:13,400 So we're always going to be vulnerable as a human population to epidemics from novel viruses that we've not seen before. 639 01:04:13,400 --> 01:04:19,990 We've seen this with Corona virus and I'm sure we will see this again in the future. 640 01:04:19,990 --> 01:04:27,940 Having just talked about novel pathogens, we then moved on to discuss a disease that we already know a great deal about. 641 01:04:27,940 --> 01:04:35,830 I think cholera is a very interesting problem and one that should probably have more attention. 642 01:04:35,830 --> 01:04:46,630 This probably causes more large scale epidemics around the world every year than other epidemic diseases. 643 01:04:46,630 --> 01:04:53,560 And yet we know an awful lot about cholera, how it is spread, how it can be controlled. 644 01:04:53,560 --> 01:05:02,980 We have treatments. We have a vaccine. And yet it occurs every year, predictably, in various parts of the world. 645 01:05:02,980 --> 01:05:10,450 And it shows that we really do need to have a holistic approach to dealing with epidemics. 646 01:05:10,450 --> 01:05:19,300 And the idea that, oh, if we have a vaccine or if we have an effective treatment, then all our problems are solved. 647 01:05:19,300 --> 01:05:26,590 It just shows that that's not the case, that even when we do have those, we need to be able to apply those. 648 01:05:26,590 --> 01:05:34,540 And we need to be thinking about improving sanitation and improving the health of populations, 649 01:05:34,540 --> 01:05:40,060 the risk and so on if we want to be able to control these diseases. 650 01:05:40,060 --> 01:05:44,290 With so many potential threats on the horizon. I asked Jemmy. 651 01:05:44,290 --> 01:05:56,170 Which diseases concern him the most? What I'd worry about from a UK perspective is an epidemic of a disease that's caused by midges. 652 01:05:56,170 --> 01:06:00,040 Midges are all over the UK. 653 01:06:00,040 --> 01:06:04,210 We have no control measures for dealing with them at all. 654 01:06:04,210 --> 01:06:11,560 Just think about people who go on holiday in Scotland in the summer and the mej population that we have there. 655 01:06:11,560 --> 01:06:24,580 If we were to get a infection that was spread by midges coming into the UK and affecting humans, then I think we would be in a very serious problem. 656 01:06:24,580 --> 01:06:33,820 We've been quite lucky. There have been two outbreaks of mej infections in the UK in recent years. 657 01:06:33,820 --> 01:06:38,230 One has been bluetongue virus and the other was Schmallenberg. 658 01:06:38,230 --> 01:06:43,300 Both of these affect animals, livestock in particular. 659 01:06:43,300 --> 01:06:48,970 But luckily for us, they don't cross into the human population. 660 01:06:48,970 --> 01:06:55,150 And the veterinary profession has been able to develop vaccines very rapidly. 661 01:06:55,150 --> 01:07:02,560 It's much easier to make a vaccine against animal diseases than it is for the human ones in terms of regulation and so on. 662 01:07:02,560 --> 01:07:05,980 And those epidemics have been controlled. 663 01:07:05,980 --> 01:07:16,600 But if either of those had spread into human populations or had an effect on humans, then I think we would have been in a very serious way, 664 01:07:16,600 --> 01:07:21,790 given the wide variety of outbreaks that any country could, in theory, have to plan for. 665 01:07:21,790 --> 01:07:27,470 I'd put to Jemmy that pandemic preparation is an almost impossible task. 666 01:07:27,470 --> 01:07:31,220 He had an interesting perspective on whether we should be optimistic or 667 01:07:31,220 --> 01:07:36,680 pessimistic about a country's ability to plan for the emergence of a new disease, 668 01:07:36,680 --> 01:07:46,310 previously pandemic flu was right up there at the top of the UK is National Risk Register. 669 01:07:46,310 --> 01:07:53,120 But that didn't translate into robust plans really to be able to control it. 670 01:07:53,120 --> 01:08:05,730 I really do feel that this current pandemic has galvanised policymakers and will make changes to the future on how we deal with this. 671 01:08:05,730 --> 01:08:08,630 So I'm optimistic that things will be done. 672 01:08:08,630 --> 01:08:19,670 I'm slightly pessimistic in that the history of dealing with epidemics is that we always put plans in place for the last epidemic, 673 01:08:19,670 --> 01:08:24,140 not for the future epidemic, but for what happened last time. 674 01:08:24,140 --> 01:08:31,940 And of course, that is very much shutting the stable door after the horse has bolted, which is difficult. 675 01:08:31,940 --> 01:08:34,220 I mean, what should we put in place? 676 01:08:34,220 --> 01:08:44,600 I'm in a position where I can be confident that there will be another pandemic or certainly major, extensive epidemic that occurs. 677 01:08:44,600 --> 01:08:50,720 But what I can't tell you is when or where or what it will be caused by. 678 01:08:50,720 --> 01:08:59,900 And that means that we need to have put in place systems that are frameworks that are adaptable 679 01:08:59,900 --> 01:09:06,260 and flexible enough to deal with epidemics of whatever sort may come about for the future. 680 01:09:06,260 --> 01:09:13,160 And it means that we have to learn on the hoof and apply what we know from first principles 681 01:09:13,160 --> 01:09:19,070 or from other diseases that we've dealt with to be able to control these epidemics. 682 01:09:19,070 --> 01:09:25,850 But it means that we do have to be prepared and we must not allow the resources to be run down so 683 01:09:25,850 --> 01:09:31,700 that we're not in a position and that it takes a long time to be able to deal with with an epidemic. 684 01:09:31,700 --> 01:09:36,050 The best time to deal with it is when it first occurs and to control it. 685 01:09:36,050 --> 01:09:40,700 Then if you allow it to get out of control, then it is much harder. 686 01:09:40,700 --> 01:09:47,630 With diseases like Corona virus, we're seeing doubling times with four days, 10 days, 687 01:09:47,630 --> 01:09:53,390 that kind development, that means that you get exponential rise very rapidly indeed. 688 01:09:53,390 --> 01:09:58,340 And you can quadruple your number of cases in a week or two. 689 01:09:58,340 --> 01:10:05,360 And that's very serious. So you need to be prepared to act very rapidly when epidemics occur. 690 01:10:05,360 --> 01:10:12,650 My final guest for today poses a more fundamental challenge to the whole way we've been thinking about epidemics. 691 01:10:12,650 --> 01:10:20,000 Erica Charters, associate professor in the history of medicine in Oxford's faculty of history, who we met in Episode five, 692 01:10:20,000 --> 01:10:29,390 cautions that concentrating too much on specific periodic outbreaks risks ignoring the constant threat of endemic disease. 693 01:10:29,390 --> 01:10:34,310 One of the really interesting things about an epidemic is that we tend to think 694 01:10:34,310 --> 01:10:38,100 about non periods of epidemics as periods when there's not disease and the past. 695 01:10:38,100 --> 01:10:41,120 That's just not true. There's always disease lurking around in the world. 696 01:10:41,120 --> 01:10:49,300 So the difference between normal periods, what we make health care is a pandemic disease and epidemic disease is when disease becomes a problem. 697 01:10:49,300 --> 01:10:54,260 There is no magical number when disease something becomes an epidemic. 698 01:10:54,260 --> 01:10:59,450 It's actually when we either feel that it's unacceptable levels or, for example, 699 01:10:59,450 --> 01:11:08,090 when policy officials deem that this disease is now a danger to the population or present some kind of risk. 700 01:11:08,090 --> 01:11:16,430 So I think the very interesting point to make here is that this means that we have to start from a baseline of acceptable levels of disease. 701 01:11:16,430 --> 01:11:19,280 And it's something that we often don't think about when we talk about epidemics, 702 01:11:19,280 --> 01:11:27,890 that actually epidemics only make sense if we also think about how it needs the context of acceptable that is endemic levels of disease. 703 01:11:27,890 --> 01:11:31,520 I'm a historian of endemic disease, probably more so than epidemic disease. 704 01:11:31,520 --> 01:11:36,110 But you can see how if you take a long term approach, if you're looking at the history of disease, 705 01:11:36,110 --> 01:11:40,580 you're going to be looking at fluctuations when something is at one point epidemic. 706 01:11:40,580 --> 01:11:46,220 And then when it's considered endemic and it's not just about as we said, it's there's probably this kind of cyclical nature, 707 01:11:46,220 --> 01:11:53,510 as you can see, how there might be a cycle when influenza becomes an epidemic disease, but it's also about spatial differences. 708 01:11:53,510 --> 01:11:58,670 So plague is a great example where we see that it recedes from some locations 709 01:11:58,670 --> 01:12:03,140 in the world and then is maintained as a constant in other parts of the world. 710 01:12:03,140 --> 01:12:10,790 And so actually, what you're calling an epidemic disease probably depends on which position in the world you happen to be placed. 711 01:12:10,790 --> 01:12:11,660 The other way of thinking about. 712 01:12:11,660 --> 01:12:20,360 This is, of course, some diseases are deemed acceptable and endemics or something like malaria is obviously endemic in some parts of the world. 713 01:12:20,360 --> 01:12:25,820 If we were to see an outbreak of malaria, say, in England, we would consider it an epidemic. 714 01:12:25,820 --> 01:12:32,550 Even that would be much. Lower rate simply because we think of that as being a foreign and somewhat unacceptable disease. 715 01:12:32,550 --> 01:12:37,980 You can see how it's as much about geography as it actually is about space and time. 716 01:12:37,980 --> 01:12:46,570 This seemed a fascinating idea. But I was curious why Erica fought epidemic diseases appear to be so much more prominent, you know, 717 01:12:46,570 --> 01:12:53,560 cultural memory than the endemic diseases that many people around the world live alongside every day. 718 01:12:53,560 --> 01:12:58,660 This is where probably it's because I'm a historian of endemic disease and I feel like we forget about endemic disease. 719 01:12:58,660 --> 01:13:03,970 Right. And it makes sense why we remember epidemics, because they are dramatic. 720 01:13:03,970 --> 01:13:09,550 They're exciting. They seem to have this storyline. People have a chance to be heroes. 721 01:13:09,550 --> 01:13:13,360 It's much harder to to write or to tell. 722 01:13:13,360 --> 01:13:18,700 Even today, I think people who are trying to raise money for fighting against endemic diseases will tell you it's much 723 01:13:18,700 --> 01:13:24,760 harder to have an exciting narrative to sell to the public about your battles against infant diarrhoea. 724 01:13:24,760 --> 01:13:29,350 Right. What is the great drama at hold there? And I think that's what's fascinating is, of course, 725 01:13:29,350 --> 01:13:37,150 endemic disease is probably much more significant in terms of mortality or even in terms of 726 01:13:37,150 --> 01:13:42,760 numbers of people who are constantly ill and therefore more susceptible to other diseases. 727 01:13:42,760 --> 01:13:48,580 But those things are much harder. So I'm always a champion of remembering endemic disease. 728 01:13:48,580 --> 01:13:53,650 One of the things that I'm working on right now is a project on how epidemics end. 729 01:13:53,650 --> 01:14:00,580 And, of course, usually how epidemics and for the most part is by turning into endemic disease, by becoming acceptable. 730 01:14:00,580 --> 01:14:04,930 There's very few stories of disease simply disappearing. 731 01:14:04,930 --> 01:14:08,140 And so I do think if we were to take into a broader context, 732 01:14:08,140 --> 01:14:14,800 that would help us to remember that actually epidemics also need to be seen within the context of endemic disease. 733 01:14:14,800 --> 01:14:22,030 I was really struck that kind of image that was going around early on in the pandemic by this website called the Visual Capoulas, 734 01:14:22,030 --> 01:14:27,400 which is about epidemics in the past. And they had these little coloured bubbles that were supposed to be representing 735 01:14:27,400 --> 01:14:30,910 numbers of people who died according to different epidemics in the past, 736 01:14:30,910 --> 01:14:38,890 stretching all the way back to show Cubitt in context. But what struck me so much as is these empty spaces between each bubble and of course, 737 01:14:38,890 --> 01:14:45,230 those empty spaces are full of endemic disease, but they just don't they don't get captured in that kind of model. 738 01:14:45,230 --> 01:14:50,080 And so we really do run the danger of just looking at the bubbles than the bubbles don't make any sense 739 01:14:50,080 --> 01:14:55,450 because we don't understand what's actually in between each of those those bubbles of epidemics. 740 01:14:55,450 --> 01:15:04,000 And Erica suggested that the most useful way of thinking about disease is something that's just part of our day to day experience. 741 01:15:04,000 --> 01:15:08,800 The really important thing to think about is that disease is something that's part of society. 742 01:15:08,800 --> 01:15:14,050 I think we tend to think about disease as something that's outside of it and maybe occasionally comes in. 743 01:15:14,050 --> 01:15:19,730 But actually, if you're taking a long term perspective, disease only makes sense within a social context. 744 01:15:19,730 --> 01:15:28,280 Right. So we can think about how there's obviously the biological phenomenon. But in terms of how it's transmitted, that depends on human activity. 745 01:15:28,280 --> 01:15:33,170 Right. So take cover at 19. It's about shaking hands or kissing cheeks or whatnot. 746 01:15:33,170 --> 01:15:38,530 So it's about human interaction. And the same way that the actual rates, the rates of mortality, for example, 747 01:15:38,530 --> 01:15:43,240 are shaped by human intervention, whether it be political or whether a medical. 748 01:15:43,240 --> 01:15:47,830 So I think actually the category of epidemic can be very helpful because it reminds us 749 01:15:47,830 --> 01:15:53,770 that disease is as much a social and political phenomenon as it is a biological one. 750 01:15:53,770 --> 01:15:59,170 But I think it's therefore very important because we tend to assume that epidemic is this kind of obvious, 751 01:15:59,170 --> 01:16:04,900 self-contained category when actually, as I've been saying, it probably depends on who's defining it. 752 01:16:04,900 --> 01:16:12,550 Who says that it is a problem? Why it's a problem. To whom it's a problem and where you're placed when you're saying that is an epidemic 753 01:16:12,550 --> 01:16:18,100 or actually that's just a normal rate of disease that we should simply accept. 754 01:16:18,100 --> 01:16:21,970 You could talk about how epidemics are very traumatic. Right. 755 01:16:21,970 --> 01:16:28,570 So these are the things that we pay lots of attention to, things like chronic diseases or infant diseases we tend not to notice. 756 01:16:28,570 --> 01:16:33,120 And so one way of thinking about this is how epidemics groups that are like the tips of icebergs. 757 01:16:33,120 --> 01:16:35,200 Right. So they are the things that are very visible. 758 01:16:35,200 --> 01:16:41,620 It's when you have a lot of government intervention, that's when people are very upset about rates of disease and deem that they're unacceptable. 759 01:16:41,620 --> 01:16:49,390 But those rates of disease actually usually depend on substantial mass of the iceberg that's underwater that often you can't see. 760 01:16:49,390 --> 01:16:54,310 One way you can think about this is comorbidities. And again, I think Covered 19 has really brought this home. 761 01:16:54,310 --> 01:17:01,600 That disease is complex, right? It interacts with other diseases, but it also interacts with different kinds of health structures, 762 01:17:01,600 --> 01:17:06,220 including things that are tied into social structures, socio economic conditions. 763 01:17:06,220 --> 01:17:11,650 Living conditions. Right. Population density. So those are the types of things that disease. 764 01:17:11,650 --> 01:17:15,910 It doesn't just strike everyone in the same way. Actually, it uncovers all of these differences. 765 01:17:15,910 --> 01:17:23,890 I think that's one way to think about this kind of broader social context for thinking about how epidemics interact within a society. 766 01:17:23,890 --> 01:17:31,630 But therefore, also how they reveal these different social structures, political differences within a society. 767 01:17:31,630 --> 01:17:33,550 We've been coming to the end of our conversation, 768 01:17:33,550 --> 01:17:40,770 but I was still keen to explore this idea of our natural bias towards remembering certain types of outbreak. 769 01:17:40,770 --> 01:17:48,510 I asked Erica, why was she thought that some diseases live on in history while others are largely forgotten? 770 01:17:48,510 --> 01:17:52,470 It's a great question because I think there's two parts to this, right. 771 01:17:52,470 --> 01:17:59,910 One is what shapes our response as to whether we think a disease is important and we can think about how some diseases 772 01:17:59,910 --> 01:18:06,000 are feared and others probably maybe because of symptoms that we can think about how Ebola has very striking, 773 01:18:06,000 --> 01:18:10,590 dramatic symptoms. Cholera, too, was very noted for having these dramatic symptoms. 774 01:18:10,590 --> 01:18:15,420 Death was very fast. So that's something that people often pick up on yellow fever, 775 01:18:15,420 --> 01:18:19,590 which kind of the term people used to describe it in the 18th century as the black vomit. 776 01:18:19,590 --> 01:18:26,670 So you can again imagine that has these very striking symptoms. So part of it has to do with the type of disease itself. 777 01:18:26,670 --> 01:18:31,410 But the other thing we can think about is, again, who is it affecting and in what ways? 778 01:18:31,410 --> 01:18:35,220 And I think this is always this debate that we have over. Is it? 779 01:18:35,220 --> 01:18:39,510 Say those in power who are affected most by this disease. 780 01:18:39,510 --> 01:18:46,470 And so therefore have reason to kind of energise political structure or invest in therapeutics towards it? 781 01:18:46,470 --> 01:18:50,400 Or is it those who are say perhaps have less political power? 782 01:18:50,400 --> 01:18:54,090 The other thing, which I think is really important is that there is a long history, 783 01:18:54,090 --> 01:18:58,770 actually, of using disease to mobilise what we might call public opinion. 784 01:18:58,770 --> 01:19:04,980 So the period that I look at in the seventeen hundreds people might be surprised to hear that even then, 785 01:19:04,980 --> 01:19:10,020 in their early days of newspapers in the 18th century in England, disease was used as a partisan criticism. 786 01:19:10,020 --> 01:19:14,040 So it was especially during wartime, because I look at soldiers and sailors, 787 01:19:14,040 --> 01:19:19,620 what you see is that it's OK for your soldiers and sailors to die from combat, 788 01:19:19,620 --> 01:19:24,600 but it's deemed very problematic if they're dying from diarrhoea or from yellow fever. 789 01:19:24,600 --> 01:19:28,290 Those are just not glorious ways or expected ways to die. 790 01:19:28,290 --> 01:19:34,230 And so reports of disease get used in the press by, you know, 791 01:19:34,230 --> 01:19:42,300 the other political party to say there's something wrong with leadership or leadership is corrupt or our foreign policy needs a rethink because 792 01:19:42,300 --> 01:19:53,520 this is far too expensive an investment to be losing our precious national manpower to yellow fever or to disease rather than to combat. 793 01:19:53,520 --> 01:20:03,630 So disease. Also has this very long history of being part of political arguments, even diplomatic arguments about who can care for their troops. 794 01:20:03,630 --> 01:20:14,550 And the best way before we finished. I had a warning to Postle about the implicit moral framework which can accompany the way we talk about disease. 795 01:20:14,550 --> 01:20:22,380 There's always a moral framework. Right. And and another way of saying that this is, although perhaps we don't always think and religious terms, 796 01:20:22,380 --> 01:20:26,070 we probably think in terms of responsibility, which is very similar. 797 01:20:26,070 --> 01:20:30,420 So I think very often when we talk about there's a sense in which disease often is, 798 01:20:30,420 --> 01:20:37,530 although we don't talk about sane people will often relate it to, well, that's because you acted inappropriately. 799 01:20:37,530 --> 01:20:45,090 You didn't take the proper cautions. I think the rhetoric about young people going out and partying obviously has very similar 800 01:20:45,090 --> 01:20:50,670 frameworks thinking about this as disease being the result of acting irresponsibly. 801 01:20:50,670 --> 01:21:00,180 So I think that's another thing to think about as look, a lot of us would know in a kind of theoretical way that disease acts somewhat randomly. 802 01:21:00,180 --> 01:21:05,940 And yet what very often happens, especially during the period of an epidemic, is that we want to make sense of it. 803 01:21:05,940 --> 01:21:10,950 So Charles Rosenberg, a wonderful is kind of medicine, but this classic piece about what is an epidemic. 804 01:21:10,950 --> 01:21:18,390 And he talks about how it's a kind of drama. It's a narrative that starts and has various stages, kind of moves to a climax. 805 01:21:18,390 --> 01:21:26,820 Has actors and characters. Part of this is this need that we have to try to make sense of what actually is in some ways a kind of random event. 806 01:21:26,820 --> 01:21:31,020 And very often it is by saying that there are good people and bad people. 807 01:21:31,020 --> 01:21:34,680 Bad things should happen to those bad people, including the outbreak of disease. And again, 808 01:21:34,680 --> 01:21:39,240 I think this is where our own argument about which countries are doing well and which countries are 809 01:21:39,240 --> 01:21:45,240 not doing well is partly our attempt to try to say we have some control over what's happening. 810 01:21:45,240 --> 01:21:51,120 And it's because if you act the right way, then you'll be able to avoid the bad outcome of disease. 811 01:21:51,120 --> 01:21:59,190 But as many people remind us, that's not a sure thing, especially when you're dealing with a new and rather unknown disease. 812 01:21:59,190 --> 01:22:04,950 Thank you for joining me. This bonus episode in our series on the history of pandemics. 813 01:22:04,950 --> 01:22:08,180 If you haven't listened to the whole series yet, please do. 814 01:22:08,180 --> 01:22:16,050 In it, I explore ten world events that may have had a significant impact on the way we think about and prepare for pandemics. 815 01:22:16,050 --> 01:22:23,400 We'd love to know what you thought of this season of future makers and to hear your recommendations for future themes. 816 01:22:23,400 --> 01:22:30,210 So please do leave a review or get in touch on social media. We'll be back soon with more episodes. 817 01:22:30,210 --> 01:22:49,330 In the meantime, I'm still Peter Milliken and you've been listening to Future Makers. 818 01:22:49,330 --> 01:22:53,640 Future Makers is created in-house at the University of Oxford. 819 01:22:53,640 --> 01:22:57,790 The school for the series was composed and recorded by Richard Watts. 820 01:22:57,790 --> 01:23:02,110 It's presented by me, Professor Peter Milliken from Hartford College. 821 01:23:02,110 --> 01:23:09,310 And the series is written and produced by Ben Harwood and Steve Pritchard, who've been a delight to work with. 822 01:23:09,310 --> 01:23:33,792 Thank you. On behalf of the whole team for listening to our history of Pandemic's.